Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study

Conclusions Olmesartan is associated with an increased risk of hospitalisation for intestinal malabsorption and coeliac disease.

http://gut.bmj.com/cgi/content/short/65/10/1664?rss=1

Source: Gut - September 7, 2016 Category: Gastroenterology Authors: Basson, M., Mezzarobba, M., Weill, A., Ricordeau, P., Allemand, H., Alla, F., Carbonnel, F. Tags: Coeliac disease, Gastrointestinal hormones Small bowel Source Type: research